Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

The projected decline in LALPATHLAB's revenues compared to last year is expected to make investors cautious. A drop in revenue often has a direct negative effect on the company's bottom line, signaling potential challenges that could undermine investor confidence and reduce overall profitability.

Financial Ratios:

currentRatio 0.00000
forwardPE 39.57900
debtToEquity 6.44100
earningsGrowth -0.06600
revenueGrowth 0.10600
grossMargins 0.58503
operatingMargins 0.20794
trailingEps 31.69000
forwardEps 35.43041

LALPATHLAB's low growth in both earnings and revenue signals a potential profit decline. This could be a sign of financial trouble, suggesting that the company's profitability might shrink in the near future.
Positive gross and operating margins for LALPATHLAB suggest that the company is operating profitably. These margins highlight LALPATHLAB's efficiency in managing costs while maintaining healthy revenue streams, contributing to its overall financial strength.
LALPATHLAB's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that LALPATHLAB is likely to outperform its previous year's financial performance.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

LALPATHLAB's price projections have been revised downward gradually, indicating that analysts are tempering their expectations. This downward shift suggests a more cautious outlook on the company's growth prospects.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


LALPATHLAB experienced 39 selling transactions, with market price of 2992.944864908854.1 purchases of LALPATHLAB stock were recorded, with market price of 3308.5 per share.No clear trend can be drawn from the insider transactions, leaving the company's next steps and outlook uncertain from this data alone.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Analysts have shown a buy bias for Dr. Lal PathLabs Limited, marking it as a favorable investment option. This could inspire investors to see Dr. Lal PathLabs Limited as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.